Insufficient scRNA-seq data for expression of QRFPR at single-cell level.
Insufficient scRNA-seq data for expression of QRFPR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 99.09 | 89 / 89 | 83% | 16.34 | 745 / 901 |
| thymus | 85% | 41.94 | 556 / 653 | 39% | 1.48 | 233 / 605 |
| adrenal gland | 88% | 21.57 | 227 / 258 | 29% | 4.94 | 66 / 230 |
| heart | 97% | 66.42 | 831 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 41% | 11.76 | 596 / 1445 | 36% | 5.05 | 65 / 183 |
| brain | 59% | 23.95 | 1547 / 2642 | 12% | 0.17 | 85 / 705 |
| ovary | 61% | 10.90 | 110 / 180 | 1% | 0.06 | 4 / 430 |
| intestine | 50% | 9.57 | 485 / 966 | 5% | 0.24 | 24 / 527 |
| prostate | 53% | 10.03 | 131 / 245 | 1% | 0.01 | 5 / 502 |
| uterus | 24% | 3.65 | 41 / 170 | 17% | 1.11 | 76 / 459 |
| adipose | 31% | 8.05 | 379 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 31% | 5.10 | 408 / 1335 | 0% | 0 | 0 / 0 |
| breast | 22% | 4.64 | 102 / 459 | 7% | 0.42 | 79 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 2.51 | 13 / 45 |
| lung | 13% | 5.29 | 76 / 578 | 15% | 1.47 | 178 / 1155 |
| skin | 16% | 1.89 | 287 / 1809 | 6% | 1.11 | 29 / 472 |
| muscle | 20% | 2.75 | 161 / 803 | 0% | 0 | 0 / 0 |
| stomach | 12% | 1.40 | 44 / 359 | 2% | 0.04 | 7 / 286 |
| bladder | 0% | 0 | 0 / 21 | 8% | 0.44 | 40 / 504 |
| pancreas | 4% | 0.35 | 14 / 328 | 2% | 0.04 | 4 / 178 |
| liver | 2% | 0.15 | 4 / 226 | 2% | 0.06 | 7 / 406 |
| peripheral blood | 0% | 0.03 | 4 / 929 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0.03 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0032870 | Biological process | cellular response to hormone stimulus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0042277 | Molecular function | peptide binding |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004983 | Molecular function | neuropeptide Y receptor activity |
| Gene name | QRFPR |
| Protein name | G protein-coupled receptor 103, isoform CRA_a (Pyroglutamylated RFamide peptide receptor) Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155) QRFPR protein Pyroglutamylated RFamide peptide receptor |
| Synonyms | GPR103 hCG_1778361 |
| Description | FUNCTION: Receptor for the orexigenic neuropeptide QRFP. The activity of this receptor is mediated by G proteins that modulate adenylate cyclase activity and intracellular calcium levels. . |
| Accessions | ENST00000394427.3 G4XH69 J3KNR3 Q96P65 ENST00000334383.9 F2Z3L3 A1A4W1 ENST00000507331.5 |